D.E. Shaw & Co
WINT

D.E. Shaw & Co’s Windtree Therapeutics Inc WINT Stock Holding History

D.E. Shaw & Co’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,537
Closed -$31K – 3991
2015
Q4 		$31K Sell
10,537
-12,066
-53% -$49.5K ﹤0.01% 3736
2015
Q3 		$95K Buy
22,603
+1
+0% +$7 ﹤0.01% 3616
2015
Q2 		$215K Buy
22,602
+8,526
+61% +$120K ﹤0.01% 3556
2015
Q1 		$235K Sell
14,076
-3,079
-18% -$60.6K ﹤0.01% 3396
2014
Q4 		$279K Sell
17,155
-4,688
-21% -$103K ﹤0.01% 3678
2014
Q3 		$562K Sell
21,843
-2,047
-9% -$49.4K ﹤0.01% 3266
2014
Q2 		$595K Sell
23,890
-1,006
-4% -$25.7K ﹤0.01% 3389
2014
Q1 		$749K Sell
24,896
-22,734
-48% -$765K ﹤0.01% 3276
2013
Q4 		$1.5M Sell
47,630
-5,520
-10% -$173K ﹤0.01% 2795
2013
Q3 		$1.46M Sell
53,150
-4,084
-7% -$99K ﹤0.01% 2706
2013
Q2 		$1.22M Buy
+57,234
New +$1.41M ﹤0.01% 2551

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

D.E. Shaw & Co's WINT Position: Q1 2016 in Review

D.E. Shaw & Co sold out of Windtree Therapeutics Inc (WINT) in Q1 2016, closing a stake of 10,537 shares — an estimated $31K sold.

D.E. Shaw & Co first reported a position in WINT in Q2 2013 and held it in 11 quarters. The position peaked at $1.5M in Q4 2013. 34 funds tracked by Wall St. Rank hold WINT as of Q1 2016.

  • D.E. Shaw & Co reported no remaining Windtree Therapeutics Inc position as of Q1 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,537 Windtree Therapeutics Inc shares in Q1 2016, an estimated $31K.
  • D.E. Shaw & Co first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 11 quarters.
  • D.E. Shaw & Co's Windtree Therapeutics Inc position peaked at $1.5M in Q4 2013.
  • 34 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.